IQGAP1 and breast carcinoma: Thus, both IQGAP1 and β-arrestins act to scaffold components of the MEK/ERK pathways [39], suggesting that IQGAP1 and β-arrestin2 may utilize the MAPK signaling cascade to regulate LPA-induced breast cancer cell invasiveness.